Monophasic vs Biphasic Contraceptives
Start with monophasic oral contraceptives as the first-line choice for women beginning hormonal contraception, as there is no evidence that biphasic formulations offer any clinical advantage in efficacy, bleeding patterns, or side effects. 1
Key Definitions
- Monophasic pills: Each active tablet contains the same fixed dose of estrogen and progestin throughout the entire cycle 1
- Biphasic pills: Contain two different dose combinations of estrogen and progestin during the cycle, with varying hormone levels 1
- Triphasic pills: Contain three different dose combinations throughout the cycle 1
Clinical Evidence and Recommendations
Efficacy
- Only one limited-quality randomized trial has directly compared biphasic versus monophasic formulations, finding no significant differences in contraceptive effectiveness 2
- No accidental pregnancy data were reported in this trial, limiting conclusions about comparative efficacy 2
- Both formulations have typical-use failure rates of approximately 9% in adults 1
Bleeding Patterns and Cycle Control
- The single available trial found no significant differences between biphasic and monophasic pills for:
Side Effects and Tolerability
- No important differences in side effect profiles have been demonstrated between biphasic and monophasic formulations 2
- Both types share similar noncontraceptive benefits including decreased menstrual cramping, reduced blood loss, and improvement in acne 1
Practical Prescribing Approach
Initial Selection
Begin adolescents and women new to oral contraceptives on a monophasic pill containing 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate. 1 This recommendation is based on:
- Extensive safety and efficacy data available for monophasic formulations 1
- No clear rationale exists for biphasic pills given the lack of demonstrated advantages 2
- Monophasic pills are simpler to use with consistent daily dosing 1
When to Consider Alternatives
- If a patient experiences unacceptable side effects or poor cycle control on the initial monophasic pill, switch to a different monophasic formulation rather than automatically moving to biphasic or triphasic options 1
- Among low-dose pills, choose formulations with the lowest copay on the patient's insurance formulary when clinically appropriate 1
Extended or Continuous Regimens
- Consider monophasic pills with shortened or eliminated hormone-free intervals for patients with:
Important Caveats
Limitations of Current Evidence
- Conclusions about biphasic versus monophasic pills are severely limited by only one available trial with methodological shortcomings 2
- The single trial examined specific formulations (norethindrone-based biphasic versus norethindrone acetate monophasic), so results may not generalize to other formulations 2
- Meta-analysis of triphasic versus monophasic trials was not possible due to differences in measuring and reporting bleeding patterns 3
Clinical Pitfalls to Avoid
- Do not assume that multiphasic formulations (biphasic or triphasic) provide better "physiologic" hormone delivery—this theoretical advantage has not translated into clinical benefits 2, 3
- Avoid switching to biphasic or triphasic pills solely to address bleeding irregularities without first trying a different monophasic formulation 1
- Do not prescribe biphasic pills as first-line when monophasic options with more robust evidence are available 2
Counseling Points
- Emphasize that 7 consecutive hormone pills are needed to prevent ovulation 1
- Provide clear instructions on missed pill management regardless of formulation type 1
- Discuss that extended or continuous monophasic regimens may cause unscheduled bleeding initially but optimize contraceptive effectiveness 1